Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1594

1.

On the immunologic basis of Rh immune globulin (anti-D) prophylaxis.

Kumpel BM.

Transfusion. 2006 Sep;46(9):1652-6. No abstract available.

PMID:
16965599
2.

The use of Rh immune globulin: a review.

Sutton GP, Jay A, Lim YS, Noland JE Jr, Boral LI.

Indiana Med. 1988 Apr;81(4):321-2. Review. No abstract available.

PMID:
2834434
3.

[Prenatal immunoglobulin prevention in Rh(D)-negative nonsensitized pregnant women].

Katsulov A.

Akush Ginekol (Sofiia). 1997;36(2):1-2. Bulgarian. No abstract available.

PMID:
9471891
5.

Rh-immunoglobulin: Rh prophylaxis.

Bowman J.

Best Pract Res Clin Haematol. 2006;19(1):27-34. Review. No abstract available.

PMID:
16377539
6.

Is the recommended minimum dose of anti-D adequate considering the rise in obesity?

Regan FA, Naftalin J, Springer V, Paterson-Brown S.

Transfus Med. 2008 Aug;18(4):266-8. doi: 10.1111/j.1365-3148.2008.00861.x. No abstract available.

PMID:
18783586
7.

[The expediency of producing antirhesus-Rh0(D) immunoglobulin and its use for preventing hemolytic disease of the newborn (for discussion)].

Mikhaĭlova AA, Klimova NIa.

Gematol Transfuziol. 1992 Jul-Aug;37(7-8):39-40. Russian. No abstract available.

PMID:
1342987
8.

[Prevention of hemolytic disease of the fetus and the newborn: it is necessary to act].

Mannessier L, Alie-Daram S, Roubinet F, Valat AS, Depoortère MH, Fournié A, Puech F.

J Gynecol Obstet Biol Reprod (Paris). 2000 Sep;29(5):441-4. Review. French. No abstract available.

9.
10.

The clinical significance of anti-G in alloimmunized pregnant women.

Hadley A, Poole J, Poole G.

Transfusion. 1997 Sep;37(9):985. No abstract available.

PMID:
9308650
11.

The prevention of Rh haemolytic disease of the fetus and newborn--general background.

Contreras M.

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:7-10. Review. No abstract available.

PMID:
9863972
12.

Early plasmapheresis followed by high-dose γ-globulin treatment saved a severely Rho-incompatible pregnancy.

Isojima S, Hisano M, Suzuki T, Sago H, Murashima A, Yamaguchi K.

J Clin Apher. 2011;26(4):216-8. doi: 10.1002/jca.20288. Epub 2011 Apr 19.

PMID:
21506141
13.

[Mechanism of action of anti-D-gamma globulin in preventing rhesus alloimmunization in the pregnant woman and hemolytic disease of the newborn infant].

Vŭlcheva B, Spasova K.

Akush Ginekol (Sofiia). 1985;24(2):73-6. Review. Bulgarian. No abstract available.

PMID:
2990248
15.

RhD hemolytic disease of the newborn.

Bowman JM.

N Engl J Med. 1998 Dec 10;339(24):1775-7. No abstract available.

PMID:
9845715
17.

The history of rhesus prophylaxis with anti-D.

Wegmann A, Glück R.

Eur J Pediatr. 1996 Oct;155(10):835-8. No abstract available.

PMID:
8891551
18.

[Rhesus prophylaxis--history and current status].

Behrens O, Lellé RJ.

Zentralbl Gynakol. 1997;119(5):204-10. German.

PMID:
9281253
19.

Increases in anti-Rh(D) titre following pregnancy.

Mollison PL.

Vox Sang. 1994;67(3):326. No abstract available.

PMID:
7863638
20.

Consensus Conference on Anti-D Prophylaxis. Edinburgh, United Kingdom, 8-9 April 1997. Papers and abstracts.

[No authors listed]

Br J Obstet Gynaecol. 1998 Nov;105 Suppl 18:iv, 1-44. Review. No abstract available.

PMID:
10328662

Supplemental Content

Support Center